Defense Threat Reduction Agency (DTRA)
Defense Threat Reduction Agency (DTRA)U.S. Department of DefenseBiography
The Defense Threat Reduction Agency (DTRA) is the intellectual, technical and operational leader for the US Department of Defense (DoD) and the U.S. Strategic Command in the effort to combat biological, chemical and nuclear threats.
While the DTRA Chemical and Biological Technologies Directorate (DTRA CB) is not part of Defense Advanced Research Projects Agency (DARPA); it is DARPA’s focal point for chemical and biological scientific and technical expertise. DTRA CB is also “dual-hatted” as the Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD) under the Department of Defense Chemical and Biological Defense Program (CBDP).
DTRA CB serves two key roles in support of DoD CBDP: Funds Manager and Joint Science and Technology Manager. The joint S&T management responsibilities include:
- Development and integration of S&T programs
- Programming, planning, and budgeting documentation for chemical and biological defense S&T programs
- Working with the JPEO-CBD to ensure effective transition of S&T efforts to advanced development
- Participating in Armed Services Biomedical Research Evaluation and Management (ASBRED) Committee meetings to ensure organizational coordination between medical and non-medical S&T liaisons such as DARPA, industry, academia, and other government agencies
- Support for DoD CB Defense S&T international programs
- Management and integration of CB Defense Advanced Concept Technology Demonstrations
DTRA and JSTO-CBD use extramural endeavors such as Broad Agency Announcements to identify, adopt, and adapt emerging and revolutionary sciences that may demonstrate high payoff potential to counter-WMD threats. Companies with applicable novel or revolutionary concepts or products are encouraged to contact DTRA.
The DTRA International Cooperative Biological Engagement Program (CBEP) works to counter threats posed by select agents, related materials, expertise, other emerging infectious disease risks, and to prevent these agents from reaching any state or non-state actors who may use them against the United States or its allies.
The CBEP mission is achieved through Biological Safety & Security capacity building; Disease Surveillance, Detection, Diagnosis, and Reporting; and Cooperative Biological Research. Through these areas CBEP aims to secure dangerous pathogens; promote open and active disease reporting and response; and advance transparent research to understanding pathogens and developing potential countermeasures. CBEP also works with partner countries to improve disease surveillance and response systems.
Notes
Articles and resources related to DTRA. Links may lead to external sites.
Featured News
CRDF Global Selected to Support Biological Threat Reduction Program Contracts
CRDF Global will mentor and train researchers at government agencies and academic institutions in the Philippines and Jordan to write competitive research proposals for international funding and to write technical articles suitable for submission to peer-reviewed publications
US Funds Animal Disease Lab in Central Luzon
The United States, through the Biological Threat Reduction Program (BTRP), has funded an advanced laboratory in Central Luzon, Philippines, in the city of Tarlac. The laboratory will conduct surveillance and testing on local agricultural samples from in and around the region.
Biodefense Archive
- Raytheon Awarded Philippines WMD Proliferation Prevention Contract
- Numerate, CUBRC Awarded DTRA Contract for ToxTool System
- SRC Awarded Contract to Integrate DREAM into the Joint Effects Model
- Chimera Secures DTRA WMD A&AS Contract
- Leidos Awarded DTRA Weather Prediction Contract
- Virginia Tech to Build Simulation System for CBRN Decision Informatics
- New Biosensor Could Help Search for Nuclear Activity
- General Dynamics Support to International Nuclear Monitoring System
- DoD, DHS Conduct Large Scale Chemical Hazard Modeling Trials
- DTRA Threat Working Group Contract Awarded to Apogee-SSU JV
- Ebola Vaccine Backed by DTRA Moves Closer to Being Licensed
- DoD to Study Omadacycline as Countermeasure for Plague, Anthrax
- DTRA/SCC-WMD Hosts the 15th C-WMD Global Synchronization Conference
- ‘Second Skin’ Protects Soldiers from Biological, Chemical Agents
- The CREATIVE Decontamination System Performance Model
- FLIR Awarded DTRA Chemical Decontamination Assurance Contract
- DTRA Awards 3.4M Contract for Ebola Countermeasure
- DTRA Seeks Proposals for Technical Support Group Services
- Coatings to Enhance Chem-Bio Agent Resistance
- JIEDDO to JIDA to JIDO: Improvised-Threat Defeat Org Moves to DTRA
- Autonomous Search Capabilities for Radiological-Nuclear Materials
- One-Handed Environmental Surface Sampling Device
- Nuclear Weapons International Monitoring System Operations
- Urban Subsystem CBRN Dispersion Modeling
- DTRA Seeks Blue Team Survivability Assessments
- In Pictures: DTRA CBD S&T Conference
- Adding Chem-Bio Detection to the PackBot
- Fundamental Research to Counter Weapons of Mass Destruction
- DTRA Creates Nuclear-Focused Directorate
- Technologies to Combat Ebola BAA
- DoD Threat Reduction Agency Builds Anti-Ebola Capacity
- We Have Military Research to Thank for Ebola Vaccines
- Micro-Rockets Can Destroy Chemical Weapons
- DTRA Awards Contract for Nuclear Treaty Verification Dialogues
- Botulinum Neurotoxin Countermeasure Discovery
- DTRA Chem-Bio BAA Contract Awards
- DTRA Seeks Counter-WMD Research Support Services
- BSL 3 Research Laboratory Opens in Kazakhstan
- Mapp Biopharmaceutical Award from DTRA for Ebola Drug
- Technology Review Shows Past and Future of Biodetection
- Cubic Awarded DTRA CBRNE Support Contract
- DTRA RFI – Nuclear Test Ban Verification Technologies
- Chem-Bio Coatings: More Than Just a Fresh Coat of Paint
- DTRA Funds Harvard Development of Biodefense Diagnostics
- BAA – New Initiatives for Nuclear Technologies Detection
- RFI – Chemical and Biological Agent Blast Environments